Kenyan pharmacists warn against using drug for genital tightening

The Pharmaceutical Society of Kenya (PSK) has cautioned Kenyan pharmacists against promoting the use of an over-the-counter antihistamine, Ajisafe, for vaginal tightening. The warning came after social media posts suggested inserting oral tablets of the drug into the vagina, despite it being formulated for oral consumption to alleviate allergy symptoms.

In a statement released on November 5, PSK President Dr Wairimu Njuki explained that the drug works by blocking histamine to treat sneezing, a runny nose, itchy eyes, and skin reactions, but it has not been approved or tested for vaginal use.

The PSK clarified that the misconception that vaginal dryness equals vaginal tightening is medically incorrect. They emphasized that even though antihistamines may cause dryness as a side effect, reduced lubrication does not strengthen vaginal muscles or alter vaginal anatomy, and may instead increase friction, discomfort, and the risk of tissue injury. The society also stressed that inserting oral tablets into the vagina is unsafe due to the lack of testing on delicate vaginal tissue.

PSK urged the public to adhere to the drug's label instructions or consult pharmacists and medical doctors before taking any medication. They also advised against relying on social media for medical information, citing the rapid spread of unverified claims as a significant public health risk. If individuals have already tried inserting the drug into their vaginas, the PSK advised them to stop immediately and seek medical attention if they experience pain, bleeding, burning, itching, unusual discharge, or fever.

The society further urged pharmacists to follow professional ethics and ensure that patients who genuinely need the drug for allergies can access it without issues. Meanwhile, media creators were encouraged to responsibly share health-related information, ensuring it is evidence-based and does not endanger the public.

The PSK reiterated its commitment to collaborating with the Pharmacy and Poisons Board, the Ministry of Health, and other healthcare professionals to safeguard medicine safety and prevent harmful practices.